Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

被引：0
|
作者：
Yoshihiro Kakeji
Kazuhiro Yoshida
Yasuhiro Kodera
Mitsugu Kochi
Takeshi Sano
Wataru Ichikawa
Sang-Woong Lee
Kazushige Shibahara
Toshio Shikano
Masato Kataoka
Atsushi Ishiguro
Hitoshi Ojima
Yoshinori Sakai
Nobuyuki Musha
Tsunenobu Takase
Taisei Kimura
Masahiro Takeuchi
Masashi Fujii
机构：
[1] Kobe University Graduate School of Medicine,Division of Gastrointestinal Surgery, Department of Surgery
[2] Gifu University,Department of Surgical Oncology
[3] Nagoya University,Department of Gastroenterological Surgery
[4] Nihon University Itabashi Hospital,Department of Digestive Surgery
[5] Cancer Institute Hospital,Gastroenterological Surgery
[6] Showa University Fujigaoka Hospital,Division of Medical Oncology
[7] Osaka Medical College,Department of General and Gastroenterological Surgery
[8] Toyama Red Cross Hospital,Department of Surgery
[9] Yokkaichi Municipal Hospital,Department of Surgery
[10] National Hospital Organization,Department of Surgery
[11] Nagoya Medical Center,Department of Medical Oncology
[12] Teine Keijinkai Hospital,Department of Gastrointestinal Surgery
[13] Gunma Prefectural Cancer Center,Department of Gastrointestinal Medicine
[14] Tsuchiura Kyodo General Hospital,Department of Surgery
[15] Saiseikai Niigata Hospital,Department of Surgery
[16] Kainan Hospital,Department of Surgery
[17] Seirei Mikatahara General Hospital,Department of Clinical Medicine, School of Pharmacy
[18] Kitasato University,undefined
来源：
Gastric Cancer | 2022年 / 25卷
关键词：
S-1; Docetaxel; Gastric cancer; Adjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：188 / 196
页数：8
相关论文
共 50 条
  • [41] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Yook, Jeong Hwan
    Park, Young-Kyu
    Lee, Jong Seok
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Park, Young Soo
    Cheong, Jae-Ho
    Jeong, Oh
    Heo, Mi Hwa
    Kim, Hark Kyun
    Park, Chohyun
    Yoo, Chang Hak
    Kang, Seok Yun
    Zang, Dae Young
    Jang, You Jin
    Sul, Ji Young
    Kim, Jong Gwang
    Kim, Beom Su
    Beom, Seung-Hoon
    Hwang, Jun-Eul
    Ryu, Seung Wan
    Kook, Myeong-Cherl
    Ryoo, Baek-Yeol
    Kim, Hyunki
    Yoo, Moon-Won
    Lee, Nam Su
    Lee, Sang Ho
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (25)
  • [42] A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)
    Nishikawa, K.
    Yoshino, S.
    Morita, S.
    Takahashi, T.
    Sakata, K.
    Nagao, J.
    Nemoto, H.
    Murakami, N.
    Matsuda, T.
    Hasegawa, H.
    Shimizu, R.
    Yoshikawa, T.
    Osanai, H.
    Imano, M.
    Naitoh, H.
    Yabe, M.
    Tanaka, A.
    Sakamoto, J.
    Saji, S.
    Oka, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S442 - S442
  • [43] FIVE-YEAR OUTCOMES OF A PHASE II STUDY OF ADJUVANT CHEMOTHERAPY WITH S-1 PLUS DOCETAXEL FOR STAGE III GASTRIC CANCER AFTER CURATIVE D2 GASTRECTOMY
    Shigeyuki, Tamura
    Kazumasa, Fujitani
    Yutaka, Kimura
    Takeshi, Tsuji
    Shohei, Iijima
    Jin, Matsuyama
    Hiroshi, Imamura
    Kentarou, Inoue
    Kenji, Kobayashi
    Yukinori, Kurokawa
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    ANNALS OF ONCOLOGY, 2014, 25 : 40 - 40
  • [44] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Wang, Xinxin
    Lu, Canrong
    Wei, Bo
    Li, Shuo
    Li, Ziyu
    Xue, Yingwei
    Ye, Yingjiang
    Zhang, Zhongtao
    Sun, Yihong
    Liang, Han
    Li, Kai
    Zhu, Linghua
    Zheng, Zhichao
    Zhou, Yanbing
    He, Yulong
    Li, Fei
    Wang, Xin
    Liang, Pin
    Huang, Hua
    Li, Guoli
    Shen, Xian
    Ji, Jiafu
    Tang, Yun
    Xu, Zekuan
    Chen, Lin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01) : 17
  • [45] Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
    Xinxin Wang
    Canrong Lu
    Bo Wei
    Shuo Li
    Ziyu Li
    Yingwei Xue
    Yingjiang Ye
    Zhongtao Zhang
    Yihong Sun
    Han Liang
    Kai Li
    Linghua Zhu
    Zhichao Zheng
    Yanbing Zhou
    Yulong He
    Fei Li
    Xin Wang
    Pin Liang
    Hua Huang
    Guoli Li
    Xian Shen
    Jiafu Ji
    Yun Tang
    Zekuan Xu
    Lin Chen
    Journal of Hematology & Oncology, 17
  • [46] Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection
    Mita, Kazuhito
    Ito, Hideto
    Ota, Emi
    Takahashi, Koudai
    Hashimoto, Masatoshi
    Asakawa, Hideki
    Hayashi, Takashi
    Fujino, Keiichi
    ANTICANCER RESEARCH, 2017, 37 (03) : 1329 - 1333
  • [47] Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
    Kasahara, Kohei
    Kunisaki, Chikara
    Sato, Sho
    Kondo, Hiroki
    Takahashi, Masazumi
    Tamura, Yuko
    Tsuchiya, Nobuhiro
    Tanaka, Yusaku
    Sato, Kei
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (06) : 2841 - 2850
  • [48] Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Chin, Keisho
    Cho, Haruhiko
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Bando, Hideaki
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Ishibashi, Takako
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [49] Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Yook, Jeong Hwan
    Park, Young-Kyu
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik-Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Yoo, Chang Hak
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Sunju
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Murata, Akihiko
    Yoshida, Kazuhiro
    Maeda, Kiyoshi
    Ikejiri, Koji
    Munemoto, Yoshinori
    Sasaki, Kazuaki
    Matsuda, Chu
    Kotake, Masanori
    Suenaga, Toyokuni
    Matsuda, Hiroyuki
    Baba, Hideo
    Hamada, Chikuma
    Oki, Eiji
    Emi, Yasunori
    Saji, Shigetoyo
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345